Opinion

Video

Key Takeaways on the Evolving COPD Treatment Landscape

Author(s):

Fernando J. Martinez, MD, MS,Nicola Hanania, MD, MS

The panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.

Video content above is prompted by the following question:

  • What are your key takeaways on the evolving COPD treatment landscape?
Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
Updates to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report Released
November 18th 2024

Updates to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report Released

Tim Smith
Checking in on the Lung Health Cohort Trial
October 29th 2024

Checking in on the Lung Health Cohort Research Study

Kevin Kunzmann
Stephanie Christenson, MD | Credit: American Lung Association
October 14th 2024

Stephanie Christenson, MD: An "Exciting" New Era in COPD Management

Patrick Campbell
Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD
September 30th 2024

Lung Imaging 2.0: How AI is Shaping the Future with Rachel Eddy, PhD

Kevin Kunzmann
FDA Approves Dupilumab as Add-On Treatment for COPD
September 27th 2024

FDA Approves Dupilumab (Dupixent) for Treatment of COPD

Tim Smith
Mirtazapine Fails to Ease Breathlessness in New Study Despite Previous Hopes
September 10th 2024

Mirtazapine Fails to Ease Breathlessness in New Study Despite Previous Hopes

Chelsie Derman
© 2024 MJH Life Sciences

All rights reserved.